Zentalis Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
52.30
|
|
Average Rating
|
4.82
|
|
# Strong Buys
|
9
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.17
|
-0.96
|
0.21
|
17.95%
|
|
2022-06-30
|
-1.19
|
-1.34
|
-0.15
|
-12.61%
|
|
2022-03-31
|
-1.22
|
-1.31
|
-0.09
|
-7.38%
|
|
2021-12-31
|
-1.49
|
-1.11
|
0.38
|
25.50%
|
|
2021-09-30
|
-1.31
|
-0.09
|
1.22
|
93.13%
|
|
2021-06-30
|
-1.17
|
-1.34
|
-0.17
|
-14.53%
|
|
2021-03-31
|
-0.97
|
-1.24
|
-0.27
|
-27.84%
|
|
2020-12-31
|
-0.95
|
-1.01
|
-0.06
|
-6.32%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.61
|
|
2021-12-31
|
-3.78
|
|
2020-12-31
|
-5.58
|